Provedor de fábrica de grifos iVIGA
Estas tres tecnoloxías sanitarias de detección de inodoros serán probadas clínicamente nos Estados Unidos, Israel e Xapón
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 Xuño. The technology gains life-saving medical insights by analysing human excrement. A compañía presentou unha serie de tres patentes que abarcan elementos do seu sensor de inodoro médico.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Xapón e China.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, A tecnoloxía de OutSense pode identificar a fonte de sangue ao longo do tracto gastrointestinal.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
Segundo o CEO de OutSense, Yfat Scialom, who predicts that “coa explosión da medicina dixital, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, enfermidade inflamatoria intestinal e infeccións do tracto urinario.
Its solution consists of a multispectral optical sensor, unha fonte de luz e un dispositivo de cribado autónomo que inclúe conexión WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Información obtida da mostra de sangue, combinado cunha análise adicional do tempo desde o sangrado ata a excreción, proporciona detalles sobre a patoloxía do sangrado. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, OutSense anunciou que CommuniCare, unha gran empresa sanitaria con máis de 90 healthcare facilities in the US, comezará a probar a súa tecnoloxía este ano. Ademais deste piloto, OutSense also plans to conduct clinical trials in Israel and Japan.
Visit More News at Viga.cc News
